<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02697695</url>
  </required_header>
  <id_info>
    <org_study_id>FF 145/2015</org_study_id>
    <nct_id>NCT02697695</nct_id>
  </id_info>
  <brief_title>Chronic Inflammation After Obesity Surgery</brief_title>
  <official_title>Impact of Obesity and Metabolic Surgery on Chronic Inflammation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sana Klinikum Offenbach</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sana Klinikum Offenbach</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the impact of obesity surgery on chronic inflammation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A retrospective study to compare the impact of laparoscopic sleeve gastrectomy (LSG),
      laparoscopic Roux-en Y- gastric bypass (LRYGB) and laparoscopic omega-loop gastric bypass
      (LOLGB) on chronic inflammation and metabolic syndrome.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Chronic inflammation</measure>
    <time_frame>one day preoperatively and 1 month, 3 month, 6 month and up to 12 month postoperatively</time_frame>
    <description>the changing of leucocytes in /nl after obesity surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fatty liver index</measure>
    <time_frame>one day preoperatively and 1 month, 3 month, 6 month and up to 12 month postoperatively</time_frame>
    <description>the changing of fatty liver index after obesity surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver enzymes</measure>
    <time_frame>one day preoperatively and 1 month, 3 month, 6 month and up to 12 month postoperatively</time_frame>
    <description>the changing of GOT in U/l, GPT in U/l, GGT in U/l, AP in U/l after obesity surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index (BMI) in kg/m²</measure>
    <time_frame>one day preoperatively and 1 month, 3 month, 6 month and up to 12 month postoperatively</time_frame>
    <description>the changing of BMI in kg/m² before and after obesity surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>weight in kg</measure>
    <time_frame>one day preoperatively and 1 month, 3 month, 6 month and up to 12 month postoperatively</time_frame>
    <description>the changing of weight before and after obesity surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>waist circumference</measure>
    <time_frame>one day preoperatively and 1 month, 3 month, 6 month and up to 12 month postoperatively</time_frame>
    <description>the changing of waist circumference in cm before and after obesity surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HbA1c</measure>
    <time_frame>one day preoperatively and 1 month, 3 month, 6 month and up to 12 month postoperatively</time_frame>
    <description>the changing of HbA1c in % and after obesity surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic inflammation II</measure>
    <time_frame>one day preoperatively and 1 month, 3 month, 6 month and up to 12 month postoperatively</time_frame>
    <description>the changing of c-reactive protein in mg/l after obesity surgery</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">500</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>laparoscopic sleeve gastrectomy</arm_group_label>
    <description>patients who underwent laparoscopic sleeve gastrectomy (LSG) due to obesity and/or metabolic syndrome</description>
  </arm_group>
  <arm_group>
    <arm_group_label>laparoscopic Roux-en-Y- gastric bypass</arm_group_label>
    <description>patients who underwent laparoscopic Roux-en-Y- gastric bypass (LRYGB) due to obesity and/or metabolic syndrome</description>
  </arm_group>
  <arm_group>
    <arm_group_label>laparoscopic omega-loop gastric bypass</arm_group_label>
    <description>patients who underwent laparoscopic omega-loop gastric bypass (LOLGB) due to obesity and/or metabolic syndrome</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Laboratory Examination</intervention_name>
    <description>Laboratory Examination before, 1 month, 3 month, 6 month and up to 12 month after LSK, LRNYGB, LOLGB</description>
    <arm_group_label>laparoscopic sleeve gastrectomy</arm_group_label>
    <arm_group_label>laparoscopic Roux-en-Y- gastric bypass</arm_group_label>
    <arm_group_label>laparoscopic omega-loop gastric bypass</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent LSG, LRYGB, LOLGB due to obesity and/or metabolic syndrome
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &gt; 35kg/m² and obesity-related disease or BMI &gt; 40kg/m²

        Exclusion Criteria:

          -  acute inflammation during laboratory examination
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rudolf Weiner, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Sana Klinikum Offenbach, Department of Obesity and Metabolic Surgery</affiliation>
  </overall_official>
  <results_reference>
    <citation>Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006 Dec 14;444(7121):860-7. Review.</citation>
    <PMID>17167474</PMID>
  </results_reference>
  <results_reference>
    <citation>Nijhuis J, Rensen SS, Slaats Y, van Dielen FM, Buurman WA, Greve JW. Neutrophil activation in morbid obesity, chronic activation of acute inflammation. Obesity (Silver Spring). 2009 Nov;17(11):2014-8. doi: 10.1038/oby.2009.113. Epub 2009 Apr 23.</citation>
    <PMID>19390527</PMID>
  </results_reference>
  <results_reference>
    <citation>Morshed G, Fathy SM. Impact of post-laparoscopic sleeve gastrectomy weight loss on C-reactive protein, lipid profile and CA-125 in morbidly obese women. Wideochir Inne Tech Maloinwazyjne. 2016 Jan;10(4):521-6. doi: 10.5114/wiitm.2015.56480. Epub 2015 Dec 15.</citation>
    <PMID>26865887</PMID>
  </results_reference>
  <results_reference>
    <citation>Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005 May;115(5):1111-9. Review.</citation>
    <PMID>15864338</PMID>
  </results_reference>
  <results_reference>
    <citation>Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004 Dec;114(12):1752-61.</citation>
    <PMID>15599400</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 20, 2016</study_first_submitted>
  <study_first_submitted_qc>March 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2016</study_first_posted>
  <last_update_submitted>April 24, 2018</last_update_submitted>
  <last_update_submitted_qc>April 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sana Klinikum Offenbach</investigator_affiliation>
    <investigator_full_name>Sonja Chiappetta, MD</investigator_full_name>
    <investigator_title>Dr. Sonja Chiappetta</investigator_title>
  </responsible_party>
  <keyword>chronic inflammation</keyword>
  <keyword>fatty liver index</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

